Name: Latest research reports of Ipca Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Motilal Oswal

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer

1404.5000 0.30 (0.02%)

NSE May 14, 2025 11:41 AM

33.51% Gain from 52W Low

Volume: 23,941

Ipca Laboratories Ltd.

14 Oct 2024, 12:00AM

1404.50

0.02%

At an inflexion point

Buy: Ipca Laboratories Ltd.

Recommendation Target

Motilal Oswal

After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.

Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.